Neuropsychopharmacology
- Control of dopamine communication by opioids: glutamate enters the discussion1 year ago
- Assisting schizophrenia diagnosis using clinical electroencephalography and interpretable graph neural networks: a real-world and cross-site study1 year ago
- The orexin neurotransmitter system as a target for medication development for opioid use disorder1 year ago
- Functional connectivity of salience and affective networks among remitted depressed patients predicts episode recurrence1 year ago
- Correction to: Pathways link environmental and genetic factors with structural brain networks and psychopathology in youth1 year ago
- Puerarin attenuates valproate-induced features of ASD in male mice via regulating Slc7a11-dependent ferroptosis1 year ago
- Bayesian dynamical system analysis of the effects of methylphenidate in children with attention-deficit/hyperactivity disorder: a randomized trial1 year ago
Journal of Psychopharmacology
- Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia3 years ago
- Activation of the aryl hydrocarbon receptor by clozapine induces preadipocyte differentiation and contributes to endothelial dysfunction3 years ago
- Sex-dependent metabolism of ketamine and (2R,6R)-hydroxynorketamine in mice and humans3 years ago
- Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study3 years ago
- Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA3 years ago
- Prospective memory deficits following acute alcohol consumption3 years ago
- Altered amygdala-cortical connectivity in individuals with Cannabis use disorder3 years ago
European Neuropsychopharmacology
- The importance of evidence synthesis in psychopharmacology: Insights from a scientometric approach2 years ago
- Contents2 years ago
- ECNP Calendar of Meetings2 years ago
- Corrigendum to ‘BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression’ European Neuropsychopharmacology Volume 58, May 2022, Pages 103-1082 years ago
- Editorial Board2 years ago
- Invisible wounds: Suturing the gap between the neurobiology, conventional and emerging therapies for posttraumatic stress disorder2 years ago
- Requiem or resurrection: Classic monoamine oxidase inhibitors revisited2 years ago